Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SQLE | Q14534 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6480330 | 1.00 | ALOX15 (0.61) | ALOX15ALDH1A1THRBTSHRSQLE | |
| SCHEMBL27489366 | 0.85 | ALOX15 (0.47) | ALOX15ALDH1A1THRBTSHRSQLE | |
| SCHEMBL929379 | 0.77 | KMT2A (0.67) | ALOX15ALDH1A1SQLEKMT2AMEN1 | |
| SCHEMBL929378 | 0.77 | KMT2A (0.67) | ALOX15ALDH1A1SQLEKMT2AMEN1 | |
| SCHEMBL929381 | 0.77 | KMT2A (0.67) | ALOX15ALDH1A1SQLEKMT2AMEN1 | |
| SCHEMBL1869475 | 0.77 | ALDH1A1 (0.38) | ALOX15ALDH1A1THRB | |
| SCHEMBL10518605 | 0.76 | ALOX15 (0.45) | ALOX15ALDH1A1TSHRKMT2AMEN1 | |
| SCHEMBL11265111 | 0.76 | ALOX15 (0.45) | ALOX15ALDH1A1TSHRKMT2AMEN1 | |
| SCHEMBL10518616 | 0.76 | ALOX15 (0.45) | ALOX15ALDH1A1TSHRKMT2AMEN1 | |
| Citronellol SCHEMBL1871004 | 0.76 | ALOX15 (1.00) | ALOX15ALDH1A1TSHRSQLEKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60190737-A | — | — | None | — | — | JP | disclosed |
| US-20050239804-A1 | Method for improved chemical synthesis of guanidinium alkaloids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-10-27 | — | — | US | disclosed |
| JP-S60190737-A | PREPARATION OF (S)-(-)-7-METHYL-3-ALKYL-6-OCTENE COMPOUND | SUNTORY LTD | 1985-09-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239804-A1 | Method for improved chemical synthesis of guanidinium alkaloids | PAICS, TYMS, IMPDH1 | ALOX15 4710/4885ALDH1A1 2442/4885THRB 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.